Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 82 results

] Title Type Year

Filters: First Letter Of Last Name is R [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

R

RP, D., J, A., Q, P., A, D., L, H., & Group, A. R. E. D. S. 2Research. (2009). Association for Research in Vision and Ophthalmology. In . presented at the 2009, Ft. Lauderdale FL.

Rowland, J. H., Varricchio, C. G., Trimble, E. L., & Gore-Langton, R. E.. (2001). Investigator-initiated health-related quality-of-life-research. Oncology, 15, 12841286-7 1291-2. presented at the 2001.

Rowland, J. H., Varricchio, C. G., Trimble, E. L., & Gore-Langton, R. E.. (2001). Health-related quality of life in cancer prevention clinical trials. Oncology, 15, 1455-7. presented at the 2001.

Rowland, J. H., Varricchio, C. G., Trimble, E. L., & Gore-Langton, R. E.. (2001). Clinical trials referral resource. Health-Related quality of life in cancer prevention clinical trials. Oncology (Williston Park), 15(11), 1455, 1458-9. presented at the 2001 Nov.

Rowland, J. H., Varricchio, C. G., Trimble, E. L., & Gore-Langton, R. E.. (2001). Clinical trials referral resource. Investigator-initiated health-related quality-of-life research. Oncology (Williston Park), 15(10), 1284, 1286-7, 1291-2, 1294. presented at the 2001 Oct.

Rowe, P. C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., et al.. (2001). Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA, 285(1), 52-9. presented at the 2001 Jan 03. doi:10.1001/jama.285.1.52

Rowe, P. C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., et al.. (2001). Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA, 285, 52-9. presented at the 2001. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11150109

Rouphael, N. G., Hurwitz, S. J., Hart, M., Beck, A., Anderson, E. J., Deye, G., et al.. (2019). Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers. Antimicrob Agents Chemother, 63(9). presented at the 2019 09. doi:10.1128/AAC.00717-19

Rossy, L. A., Buckelew, S. P., Dorr, N., Hagglund, K. J., Thayer, J. F., McIntosh, M. J., et al.. (1999). A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med, 21(2), 180-91. presented at the 1999 Spring. doi:10.1007/BF02908299

Rossy, L. A., Buckelew, S. P., Dorr, N., Hagglund, K. J., Thayer, J. S., McIntosh, M. J., et al.. (1999). A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med, 21, 180-191. presented at the 1999.

Ross, A. E., Feng, F. Y., Ghadessi, M., Erho, N., Crisan, A., Buerki, C., et al.. (2014). A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis, 17(1), 64-9. presented at the 2014 Mar. doi:10.1038/pcan.2013.49

Ross, A., Ghadessi, M., Davicioni, E., Crisan, A., Buerki, C., Erho, N., et al.. (2013). Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy. In American Society of Clinical Oncology, Genitourinary Cancers Symposium. presented at the 14/02/2013, Orlando, FL. Retrieved from http://gucasym.org/past-symposia

Ross, S. A., Pati, P., Jensen, T. L., Goll, J. B., Gelber, C. E., Singh, A., et al.. (2020). Cytomegalovirus Genetic Diversity Following Primary Infection. J Infect Dis, 221(5), 715-720. presented at the 2020 Feb 18. doi:10.1093/infdis/jiz507

Ross, A. E., Den, R. B., Yousefi, K., Trock, B. J., Tosoian, J., Davicioni, E., et al.. (2016). Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk. Prostate Cancer Prostatic Dis, 19(3), 277-82. presented at the 2016 09. doi:10.1038/pcan.2016.15

Ross, A. E., Ghadessi, M., Davicioni, E., Crisan, A., Buerki, C., Erho, N., et al.. (2013). Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy. In American Society of Clinical Oncology (ASCO) 2013. presented at the 31/05/2013, Chicago, IL. Retrieved from http://meetinglibrary.asco.org/content/114184-132

Ross, A. E., Feng, F. Y., Ghadessi, M., Erho, N., Crisan, A., Buerki, C., et al.. (2014). A Genomic Classifier Predicting Metastatic Disease Progression in Men with Biochemical Recurrence After Prostatectomy. Prostate Cancer Prostatic Dis, 17, 64-69. presented at the 03/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24145624

Ross, A. E., Ghadessi, M., Davicioni, E., Crisan, A., Buerki, C., Erho, N., et al.. (2013). Performance of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with Biochemical Recurrence Post Radical Prostatectomy. In American Urological Association Annual Meeting. presented at the 04/05/2013, San Diego, CA. Retrieved from http://www.aua2013.org/

Ross, A. E., Ghadessi, M., Davicioni, E., Crisan, A., Buerki, C., Erho, N., et al.. (2013). Comparison of Clinical and Genomic Models for Prediction of Rapid Metastatic Disease after Radical Prostatectomy. In American Urological Association Annual Meeting. presented at the 04/05/2013, San Diego, CA. Retrieved from http://www.aua2013.org/

Rosenthal, J., Kim, J., de Monastario, F., Thompson, D. J. S., Bone, R., Landrum, J., et al.. (2006). Dose Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older. Invest Ophthalmol Vis Sci, 47, 5227-5233. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17122107

Rosenthal, J. M., Kim, J., de Monasterio, F., de Monastario, F., Thompson, D. J. S., Bone, R. A., et al.. (2006). Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci, 47(12), 5227-33. presented at the 2006 Dec. doi:10.1167/iovs.05-1513

Rosenthal, J. M., SanGiovanni, J. P., Chew, E. Y., Seddon, J. M., Ferris, F. L., & Group, A. - R. Eye Diseas. (2005). Dietary Zinc and Risk for Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 2005, Fort Lauderdale, FL.

Rosenberg, D., Tucker, G., & Barrow, I.. (2011). A Web-Based Study Product Verification Utility for Blinded Treatment of Food Allergy Subjects. In The Society for Clinical Trials 32nd Annual Meeting. presented at the 05/2011, Vancouver, BC, Canada. Retrieved from http://www.sctweb.org/public/meetings/2011/home.cfm

Rooney, L., Covington, L., Dedier, A., & Samuel, B.. (2019). Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool. J Empir Res Hum Res Ethics, 14(2), 95-106. presented at the 2019 04. doi:10.1177/1556264619831888

Romero, J., Cohen, A., Boron, M., Rankin, M., & Group, theSynagis Ou. (2004). RSV prophylaxis in minority populations; results from the Palivizumab Outcomes Registry 2002-2003. presented at the 2004.

Roland, M., Stablein, D., Bredt, B., Munoz-Marino, B., Carlson, L., McCune, J., et al.. (2003). No Changes in Immune Activation Phenotypes, Response to Antigen, or CD8+ T-cell Mediated HIV Suppression in Transplant Recipients Receiving Immunosuppression. presented at the 2003.

1
2
3
4
next
last